The Latest Acorn Regulatory Newsletter
Last month’s webinar, hosted in association with TOPRA, was fully booked and very well received by attendees. You can watch the presentation element of the webinar by clicking below. We have a wide range of Brexit resources and you can access them by clicking here.
Feel free to share the newsletter with any of your colleagues. You can use the sharing buttons above.
Watch The Northern Ireland Protocol Webinar Video
Acorn Regulatory hosted a webinar in association with TOPRA on March 4th, 2021 to look at the issue of the Northern Ireland Protocol from a consultancy standpoint. The webinar was a fully booked event and generated significant interest among regulatory professionals with attendees joining from around the world.
The video of the presentation is now available and you can watch it by clicking below.
Acorn Regulatory Secures MIA Licence
Acorn Regulatory has obtained a Manufacturer’s / Importer’s Authorisation (MIA) licence (otherwise known as an MIA Licence) for Batch Certification of Imported Medicinal Products for Veterinary Use.
Download Our Repeat Use Procedure Slide Deck
The issue of Repeat Use Procedures generates many questions to our pharmaceutical regulatory affairs team. We have created a slide deck looking at the main points to consider when completing a Repeat Sue Procedure. You can download it below.
MDR Regulatory Affairs Consultants
MDR (the medical device regulations) will present the most significant changes in the device sector for a generation. Our MDR regulatory affairs consultants are ready to assist your company with any issues related to the new regulations.
Do You Need A WDA? Here Is What You Need To Know
There has been an increase in the number of companies that have sought our services to assist them in obtaining a WDA. If your company needs a WDA, we can assist you with the process in a timely and professional manner. This blog from our Quality team looks at the issues that you will need to consider if you need a WDA.
The 5 Responsibilities of the PRRC
This article is part of our series of MDR articles that look at the changes coming into play with the new medical device regulations. In this article, we are looking at the role of the Person Responsible for Regulatory Compliance (PRRC).
Acorn Regulatory’s Pharmaceutical Team
Our pharmaceutical regulatory affairs team is staffed by experts who have considerable expertise in the sector. Every team member has at least 15 years of experience in the pharmaceutical sector assisting pharmaceutical companies with their regulatory issues. Since 2002, our pharmaceutical regulatory affairs specialists have been working with clients all over the world.